Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
The obesity epidemic is a major threat to health in most countries [ 1 ], although the increase in the prevalence of obesity seems to have stopped in some countries according to recent investigations [ 2 , 3 ]. The international focus on
Search for other papers by Érique José F. Peixoto de Miranda in
Google Scholar
PubMed
Search for other papers by Márcio Sommer Bittencourt in
Google Scholar
PubMed
Search for other papers by Itamar S. Santos in
Google Scholar
PubMed
Search for other papers by Paulo A. Lotufo in
Google Scholar
PubMed
Search for other papers by Isabela M. Benseñor in
Google Scholar
PubMed
individuals with TSH values exceeding 7.0 mIU/l, and particularly above 10 mIU/l [ 6 ]. In spite of this controversy, some studies have linked SCH with hypertension [ 7 ], obesity [ 8 ], dyslipidemia [ 9 ], metabolic syndrome [ 10 ], insulin resistance [ 10
Search for other papers by K. Alexander Iwen in
Google Scholar
PubMed
Search for other papers by Erich Schröder in
Google Scholar
PubMed
Department of Endocrinology, The Christie Manchester Academic Health Science Centre, Manchester, UK
Search for other papers by Georg Brabant in
Google Scholar
PubMed
insulin resistance as an essential causative factor, has been defined as the presence of visceral obesity with at least two of the following disorders: (1) raised triglyceride level or specific treatment, (2) reduced HDL cholesterol or specific treatment
Department of Medicine, Thyroid Outpatient Clinic, Division of Endocrinology, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil
Search for other papers by Carolina Castro Porto Silva Janovsky in
Google Scholar
PubMed
Search for other papers by Fernando H. Cesena in
Google Scholar
PubMed
Search for other papers by Viviane Arevalo Tabone Valente in
Google Scholar
PubMed
Search for other papers by Raquel Dilguerian de Oliveira Conceição in
Google Scholar
PubMed
Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil
Search for other papers by Raul D. Santos in
Google Scholar
PubMed
School of Medicine, Faculdade Israelita de Ciências da Saúde Albert Einstein, Sao Paulo, Brazil
Center for Clinical and Epidemiological Research, University Hospital, University of São Paulo School of Medicine, Sao Paulo, Brazil
Search for other papers by Márcio Sommer Bittencourt in
Google Scholar
PubMed
demonstrate this independent association. NAFLD is the most common liver disorder in Western industrialized countries and shares the same risk factors as type 2 diabetes, dyslipidemia, obesity, and metabolic syndrome [ 34 ]. Indeed, it may often be
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Laura P.B. Elbers in
Google Scholar
PubMed
Search for other papers by Hjalmar A. Boon in
Google Scholar
PubMed
Search for other papers by Maaike I. Moes in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Bregje van Zaane in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Dees P.M. Brandjes in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Harry R. Büller in
Google Scholar
PubMed
Einthoven Laboratory for Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Suzanne Cannegieter in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Victor E.A. Gerdes in
Google Scholar
PubMed
), former bleeding and obesity-associated comorbidities (diabetes, hypertension, dyslipidemia, obstructive sleep apnea), presence of other established risk factors for bleeding (heart failure, renal insufficiency, bleeding disorder, prior abdominal surgery
Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
Search for other papers by Carlo Cappelli in
Google Scholar
PubMed
Search for other papers by Cristina Ciuoli in
Google Scholar
PubMed
Search for other papers by Francesca Coperchini in
Google Scholar
PubMed
Search for other papers by Francesco Chiofalo in
Google Scholar
PubMed
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Paola Palmitesta in
Google Scholar
PubMed
Search for other papers by Luca Chiovato in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
/or lifestyle factors [ 2 , 3 ]. Among well-recognized risk factors for thyroid cancer (previous radiation exposure, iodine intake, family history of thyroid disease and TSH levels), obesity has been added to the list of potential risk factors [ 4 ]. In the USA
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Laura Croce in
Google Scholar
PubMed
Search for other papers by Fausta Beneventi in
Google Scholar
PubMed
Search for other papers by Federica Ripepi in
Google Scholar
PubMed
Search for other papers by Irene De Maggio in
Google Scholar
PubMed
Search for other papers by Alberto Malovini in
Google Scholar
PubMed
Search for other papers by Camilla Bellingeri in
Google Scholar
PubMed
Search for other papers by Francesca Coperchini in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Marsida Teliti in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Arsenio Spinillo in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Flavia Magri in
Google Scholar
PubMed
iodine deficiency ( 13 ). Moreover, patients living with morbid obesity frequently experience a raised serum TSH, in the absence of positivity for thyroid autoantibodies and/or abnormal findings at thyroid ultrasound ( 14 ). The physiopathology and
Search for other papers by Hicham Benabdelkamel in
Google Scholar
PubMed
Search for other papers by Malak A Jaber in
Google Scholar
PubMed
Search for other papers by Lina A Dahabiyeh in
Google Scholar
PubMed
Search for other papers by Afshan Masood in
Google Scholar
PubMed
Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for other papers by Reem H Almalki in
Google Scholar
PubMed
Search for other papers by Mohthash Musambil in
Google Scholar
PubMed
Department of Medicine, College of Medicine and King Saud Medical City, King Saud University, Riyadh, Saudi Arabia
Search for other papers by Anas M Abdel Rahman in
Google Scholar
PubMed
Department of Biochemistry and Molecular Medicine, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
Search for other papers by Assim A Alfadda in
Google Scholar
PubMed
(registration no. E-10-172). The recruited patients, referred to the KKUH Obesity Research Center, were asked to sign a written informed consent form before enrolment. Eighteen overweight patients (10 women and 8 men) with BMI ranging from 25 to 27 kg/m 2 who
Search for other papers by Victor J M Pop in
Google Scholar
PubMed
Search for other papers by Johannes G Krabbe in
Google Scholar
PubMed
Search for other papers by Maarten Broeren in
Google Scholar
PubMed
Search for other papers by Wilmar Wiersinga in
Google Scholar
PubMed
Search for other papers by Margaret P Rayman in
Google Scholar
PubMed
/L ( Table 1 ). There were 222 (9.9%) obese women with a BMI >30 (WHO criteria). In Table 2 , the characteristics of the IH group are compared with that of the reference group. Table 2 Characteristics at 12 weeks gestation of 122 women with IH (FT4
Department of Medicine, University of Leipzig, Leipzig, Germany
Search for other papers by Lisa Volke in
Google Scholar
PubMed
Department of Medicine, University of Leipzig, Leipzig, Germany
Search for other papers by Kerstin Krause in
Google Scholar
PubMed
a study of Reinehr et al. [ 11 ], TSH and T3 were reversibly related to body weight in patients before and after weight loss (obese patients) and weight gain (anorectic patients). However, treatment of obesity and related metabolic diseases with TH